161 related articles for article (PubMed ID: 2859667)
1. Cyclophosphamide teratogenesis: a review.
Mirkes PE
Teratog Carcinog Mutagen; 1985; 5(2):75-88. PubMed ID: 2859667
[TBL] [Abstract][Full Text] [Related]
2. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of cyclophosphamide and its metabolites 4-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphoramide mustard in a high-dose combination with Thiotepa and Carboplatin.
de Jonge ME; Huitema AD; van Dam SM; Rodenhuis S; Beijnen JH
Ther Drug Monit; 2005 Dec; 27(6):756-65. PubMed ID: 16306851
[TBL] [Abstract][Full Text] [Related]
4. Morphological and biochemical aspects of monofunctional phosphoramide mustard teratogenicity in rat embryos cultured in vitro.
Mirkes PE; Greenaway JC; Hilton J; Brundrett R
Teratology; 1985 Oct; 32(2):241-9. PubMed ID: 4049282
[TBL] [Abstract][Full Text] [Related]
5. Effects of 4-hydroperoxycyclophosphamide (4-OOH-CP) and 4-hydroperoxydechlorocyclophosphamide (4-OOH-deCICP) on the cell cycle of post implantation rat embryos.
Little SA; Mirkes PE
Teratology; 1992 Feb; 45(2):163-73. PubMed ID: 1615426
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the teratogenic potential of acrolein and cyclophosphamide in a rat embryo culture system.
Schmid BP; Goulding E; Kitchin K; Sanyal MK
Toxicology; 1981; 22(3):235-43. PubMed ID: 7340013
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
Crook TR; Souhami RL; McLean AE
Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
[TBL] [Abstract][Full Text] [Related]
8. DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroperoxycyclophosphamide and phosphoramide mustard in postimplantation rat embryos.
Little SA; Mirkes PE
Cancer Res; 1987 Oct; 47(20):5421-6. PubMed ID: 3477317
[TBL] [Abstract][Full Text] [Related]
9. p53 regulates cyclophosphamide teratogenesis by controlling caspases 3, 8, 9 activation and NF-kappaB DNA binding.
Pekar O; Molotski N; Savion S; Fein A; Toder V; Torchinsky A
Reproduction; 2007 Aug; 134(2):379-88. PubMed ID: 17660247
[TBL] [Abstract][Full Text] [Related]
10. Relative mutagenicity and teratogenicity of cyclophosphamide and two of its structural analogs.
Hales BF
Biochem Pharmacol; 1983 Dec; 32(24):3791-5. PubMed ID: 6362674
[TBL] [Abstract][Full Text] [Related]
11. Role of the 4-hydroxy intermediate in the in vitro embryotoxicity of cyclophosphamide and dechlorocyclophosphamide.
Slott VL; Hales BF
Toxicol Appl Pharmacol; 1988 Feb; 92(2):170-8. PubMed ID: 3341031
[TBL] [Abstract][Full Text] [Related]
12. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos.
Little SA; Mirkes PE
Teratology; 1990 Feb; 41(2):223-31. PubMed ID: 2321166
[TBL] [Abstract][Full Text] [Related]
13. Toxicity, interstrand cross-links and DNA fragmentation induced by 'activated' cyclophosphamide in yeast: comparative studies on 4-hydroperoxy-cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor-nitrogen mustard.
Fleer R; Brendel M
Chem Biol Interact; 1982 Mar; 39(1):1-15. PubMed ID: 7037214
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide-induced teratogenesis in ICR mice: the role of apoptosis.
Torchinsky A; Savion S; Gorivodsky M; Shepshelovich J; Zaslavsky Z; Fein A; Toder V
Teratog Carcinog Mutagen; 1995; 15(4):179-90. PubMed ID: 8838632
[TBL] [Abstract][Full Text] [Related]
15. Preventive effect of piperonyl butoxide on cyclophosphamide-induced teratogenesis in rats.
Park D; Kim S; Kang H; Oh J; Jang JY; Shin S; Kim TK; Choi YJ; Lee SH; Kim KY; Joo SS; Kim YB
Birth Defects Res B Dev Reprod Toxicol; 2009 Oct; 86(5):402-8. PubMed ID: 19851987
[TBL] [Abstract][Full Text] [Related]
16. Transplacental teratogenesis and mutagenesis in mouse fetuses treated with cyclophosphamide.
Porter AJ; Singh SM
Teratog Carcinog Mutagen; 1988; 8(4):191-203. PubMed ID: 2906177
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.
Wilmer JL; Erexson GL; Kligerman AD
Cancer Res; 1986 Jan; 46(1):203-10. PubMed ID: 3079586
[TBL] [Abstract][Full Text] [Related]
19. The effect of oxygen concentration on the teratogenicity of salicylate, niridazole, cyclophosphamide, and phosphoramide mustard in rat embryos in vitro.
Greenaway JC; Mirkes PE; Walker EA; Juchau MR; Shepard TH; Fantel AG
Teratology; 1985 Oct; 32(2):287-95. PubMed ID: 4049287
[TBL] [Abstract][Full Text] [Related]
20. A kinetic analysis of rat embryo response to cyclophosphamide exposure in vitro.
Mirkes PE; Greenaway JC; Shepard TH
Teratology; 1983 Oct; 28(2):249-56. PubMed ID: 6648829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
